02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

246 GARLIC<br />

(1981): Martinescu E, Rev Med Chir Soc Med Nat Iasi 85(3), 541<br />

(1980): Mitchell JC, Contact Dermatitis 6(5), 356<br />

Hemorrhage<br />

(2002): Carden SM+, Clin Experiment Ophthalmol 30(4), 303<br />

Pemphigus<br />

(1996): Ruocco V+, Dermatology 192(4), 373<br />

Sensitization<br />

(2002): Moneret-Vautrin DA+, Allerg Immunol (Paris) 34(4), 135<br />

Urticaria<br />

(2001): McGovern TW+, Cutis 67, 193 (passim)<br />

Mucosal<br />

Cheilitis<br />

(2007): Ekeowa-Anderson AL+, Contact Dermatitis 56(3), 174<br />

Stomatodynia<br />

Eyes<br />

Rhinoconjunctivitis<br />

(2002): Jimenez-Timon A+, Allergol Immunopathol (Madr)<br />

30(5), 295<br />

Other<br />

Anaphylactoid reactions/Anaphylaxis<br />

(1999): Perez-Pimiento AJ+ 54(6), 626<br />

Hypersensitivity<br />

(2001): McGovern TW+, Cutis 67, 193 (passim)<br />

(1982): Campolmi P+, Contact Dermatitis 8(5), 352<br />

GATIFLOXACIN<br />

Trade name: Tequin (Bristol-Myers Squibb)<br />

Indications: Various infections caused by susceptible organisms<br />

Category: Antibiotic, quinolone<br />

Half-life: 7–14 hours<br />

Clinically important, potentially hazardous interactions<br />

with: amiodarone, arsenic, bepridil, bretylium, disopyramide,<br />

erythromycin, phenothiazines, procainamide, quinidine, sotalol,<br />

tricyclic antidepressants, zinc<br />

Reactions<br />

Skin<br />

Allergic reactions (sic) (0.1–3%)<br />

(2002): Medeiros EA, Braz J Infect Dis 6(4), 149 (0.18%)<br />

Angioedema<br />

Burning<br />

Diaphoresis (0.1–3%)<br />

Edema (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!